Effects of intestinal helminth infections in early childhood on immune response, inflammation, anaemia and malnutrition

ISRCTN ISRCTN83988447
DOI https://doi.org/10.1186/ISRCTN83988447
Secondary identifying numbers 063122
Submission date
22/07/2005
Registration date
22/07/2005
Last edited
13/12/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Haematological Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Not provided at time of registration

Contact information

Ms Rebecca J Stoltzfus
Scientific

Cornell University
Division of Nutritional Sciences
120 Savage Hall
Ithaca NY
14853
United States of America

Phone +1 607 255 7671
Email rjs62@cornell.edu

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study hypothesisTo test whether anthelminthic treatment of children six to 36 months of age decreases severe anaemia, decreases wasting malnutrition, and decreases anorexia.
Ethics approval(s)Not provided at time of registration
ConditionAnaemia, protein-energy malnutrition, anorexia
InterventionDouble blind Randomised Controlled Trial (RCT) of mebendazole versus an identical-looking but inert placebo.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Mebendazole
Primary outcome measure1. Haemoglobin less than 70 g/l
2. Mid upper arm circumference less than -2 Z scores of international reference
3. Maternal report of anorexia
Secondary outcome measures1. Weight-for-height less than -1 Z scores of international reference
2. Height-for-age less than -2 Z scores on international reference
3. Inflammation
Overall study start date01/01/2004
Overall study end date31/03/2006

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit6 Months
Upper age limit24 Months
SexBoth
Target number of participants2500
Participant inclusion criteria1. Six to 24 months of age
2. Informed consent
3. Residing in selected communities based on geographic catchment area
Participant exclusion criteria1. Haemoglobin less than 70 g/l
2. Refusal of informed consent
Recruitment start date01/01/2004
Recruitment end date31/03/2006

Locations

Countries of recruitment

  • Tanzania
  • United States of America

Study participating centre

Cornell University
Ithaca NY
14853
United States of America

Sponsor information

Cornell University (USA)
University/education

Division of Nutritional Sciences
Ithaca, NY
14853
United States of America

Phone +1 607 255 2946
Email crf1@cornell.edu
Website http://www.cornell.edu/
ROR logo "ROR" https://ror.org/05bnh6r87

Funders

Funder type

Charity

The Wellcome Trust (UK) (grant ref: 063122)

No information available

Burroughs Wellcome Initiative (USA)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan